img

Global Expression Competent Cells Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Expression Competent Cells Market Insights, Forecast to 2034

The Protein Expression Competent Cell Pack lets you efficiently economically optimize expression by simultaneously testing multiple strains with your gene of interest. The pack includes BL21(DE3) competent cells for nontoxic proteins and BL21(DE3) pLysS competent cells for both toxic and nontoxic proteins.
Market Analysis and InsightsGlobal Expression Competent Cells Market
Global Expression Competent Cells market is expected to reach to US$ 418.9 million in 2023, with a positive growth of %, compared with US$ 382.5 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Expression Competent Cells industry is evaluated to reach US$ 746.9 million in 2033. The CAGR will be 10.1% during 2023 to 2033.
Globally, Expression Competent Cells key companies include Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech and New England Biolabs, etc. Merck KGaA, Thermo Fisher Scientific, Agilent Technologies are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Expression Competent Cells were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Expression Competent Cells market and estimated to attract more attentions from industry insiders and investors.
Expression Competent Cells can be divided into Chemically Competent Cells and Electrocompetent Cells, etc. Chemically Competent Cells is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Expression Competent Cells is widely used in various fields, such as Protein Expression and Other, etc. Protein Expression provides greatest supports to the Expression Competent Cells industry development. In 2022, global % revenue of Expression Competent Cells went into Protein Expression filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Expression Competent Cells market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Expression Competent Cells market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
Segment by Type
Chemically Competent Cells
Electrocompetent Cells

Segment by Application


Protein Expression
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Expression Competent Cells introduction, etc. Expression Competent Cells Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Expression Competent Cells
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Expression Competent Cells Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Chemically Competent Cells
1.2.3 Electrocompetent Cells
1.3 Market by Application
1.3.1 Global Expression Competent Cells Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Protein Expression
1.3.3 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Expression Competent Cells Market Perspective (2018-2033)
2.2 Global Expression Competent Cells Growth Trends by Region
2.2.1 Expression Competent Cells Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Expression Competent Cells Historic Market Size by Region (2018-2023)
2.2.3 Expression Competent Cells Forecasted Market Size by Region (2024-2033)
2.3 Expression Competent Cells Market Dynamics
2.3.1 Expression Competent Cells Industry Trends
2.3.2 Expression Competent Cells Market Drivers
2.3.3 Expression Competent Cells Market Challenges
2.3.4 Expression Competent Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Expression Competent Cells by Players
3.1.1 Global Expression Competent Cells Revenue by Players (2018-2023)
3.1.2 Global Expression Competent Cells Revenue Market Share by Players (2018-2023)
3.2 Global Expression Competent Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Expression Competent Cells, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Expression Competent Cells Market Concentration Ratio
3.4.1 Global Expression Competent Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Expression Competent Cells Revenue in 2022
3.5 Global Key Players of Expression Competent Cells Head office and Area Served
3.6 Global Key Players of Expression Competent Cells, Product and Application
3.7 Global Key Players of Expression Competent Cells, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Expression Competent Cells Breakdown Data by Type
4.1 Global Expression Competent Cells Historic Market Size by Type (2018-2023)
4.2 Global Expression Competent Cells Forecasted Market Size by Type (2024-2033)
5 Expression Competent Cells Breakdown Data by Application
5.1 Global Expression Competent Cells Historic Market Size by Application (2018-2023)
5.2 Global Expression Competent Cells Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Expression Competent Cells Market Size (2018-2033)
6.2 North America Expression Competent Cells Market Size by Type
6.2.1 North America Expression Competent Cells Market Size by Type (2018-2023)
6.2.2 North America Expression Competent Cells Market Size by Type (2024-2033)
6.2.3 North America Expression Competent Cells Market Share by Type (2018-2033)
6.3 North America Expression Competent Cells Market Size by Application
6.3.1 North America Expression Competent Cells Market Size by Application (2018-2023)
6.3.2 North America Expression Competent Cells Market Size by Application (2024-2033)
6.3.3 North America Expression Competent Cells Market Share by Application (2018-2033)
6.4 North America Expression Competent Cells Market Size by Country
6.4.1 North America Expression Competent Cells Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Expression Competent Cells Market Size by Country (2018-2023)
6.4.3 North America Expression Competent Cells Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Expression Competent Cells Market Size (2018-2033)
7.2 Europe Expression Competent Cells Market Size by Type
7.2.1 Europe Expression Competent Cells Market Size by Type (2018-2023)
7.2.2 Europe Expression Competent Cells Market Size by Type (2024-2033)
7.2.3 Europe Expression Competent Cells Market Share by Type (2018-2033)
7.3 Europe Expression Competent Cells Market Size by Application
7.3.1 Europe Expression Competent Cells Market Size by Application (2018-2023)
7.3.2 Europe Expression Competent Cells Market Size by Application (2024-2033)
7.3.3 Europe Expression Competent Cells Market Share by Application (2018-2033)
7.4 Europe Expression Competent Cells Market Size by Country
7.4.1 Europe Expression Competent Cells Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Expression Competent Cells Market Size by Country (2018-2023)
7.4.3 Europe Expression Competent Cells Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Expression Competent Cells Market Size (2018-2033)
8.2 China Expression Competent Cells Market Size by Type
8.2.1 China Expression Competent Cells Market Size by Type (2018-2023)
8.2.2 China Expression Competent Cells Market Size by Type (2024-2033)
8.2.3 China Expression Competent Cells Market Share by Type (2018-2033)
8.3 China Expression Competent Cells Market Size by Application
8.3.1 China Expression Competent Cells Market Size by Application (2018-2023)
8.3.2 China Expression Competent Cells Market Size by Application (2024-2033)
8.3.3 China Expression Competent Cells Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Expression Competent Cells Market Size (2018-2033)
9.2 Asia Expression Competent Cells Market Size by Type
9.2.1 Asia Expression Competent Cells Market Size by Type (2018-2023)
9.2.2 Asia Expression Competent Cells Market Size by Type (2024-2033)
9.2.3 Asia Expression Competent Cells Market Share by Type (2018-2033)
9.3 Asia Expression Competent Cells Market Size by Application
9.3.1 Asia Expression Competent Cells Market Size by Application (2018-2023)
9.3.2 Asia Expression Competent Cells Market Size by Application (2024-2033)
9.3.3 Asia Expression Competent Cells Market Share by Application (2018-2033)
9.4 Asia Expression Competent Cells Market Size by Region
9.4.1 Asia Expression Competent Cells Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Expression Competent Cells Market Size by Region (2018-2023)
9.4.3 Asia Expression Competent Cells Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Expression Competent Cells Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Expression Competent Cells Market Size by Type
10.2.1 Middle East, Africa, and Latin America Expression Competent Cells Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Expression Competent Cells Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Expression Competent Cells Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Expression Competent Cells Market Size by Application
10.3.1 Middle East, Africa, and Latin America Expression Competent Cells Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Expression Competent Cells Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Expression Competent Cells Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Expression Competent Cells Market Size by Country
10.4.1 Middle East, Africa, and Latin America Expression Competent Cells Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Expression Competent Cells Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Expression Competent Cells Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Expression Competent Cells Introduction
11.1.4 Merck KGaA Revenue in Expression Competent Cells Business (2018-2023)
11.1.5 Merck KGaA Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Expression Competent Cells Introduction
11.2.4 Thermo Fisher Scientific Revenue in Expression Competent Cells Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Expression Competent Cells Introduction
11.3.4 Agilent Technologies Revenue in Expression Competent Cells Business (2018-2023)
11.3.5 Agilent Technologies Recent Developments
11.4 Takara Bio
11.4.1 Takara Bio Company Details
11.4.2 Takara Bio Business Overview
11.4.3 Takara Bio Expression Competent Cells Introduction
11.4.4 Takara Bio Revenue in Expression Competent Cells Business (2018-2023)
11.4.5 Takara Bio Recent Developments
11.5 Promega Corporation
11.5.1 Promega Corporation Company Details
11.5.2 Promega Corporation Business Overview
11.5.3 Promega Corporation Expression Competent Cells Introduction
11.5.4 Promega Corporation Revenue in Expression Competent Cells Business (2018-2023)
11.5.5 Promega Corporation Recent Developments
11.6 Beijing TransGen Biotech
11.6.1 Beijing TransGen Biotech Company Details
11.6.2 Beijing TransGen Biotech Business Overview
11.6.3 Beijing TransGen Biotech Expression Competent Cells Introduction
11.6.4 Beijing TransGen Biotech Revenue in Expression Competent Cells Business (2018-2023)
11.6.5 Beijing TransGen Biotech Recent Developments
11.7 GeneScript Corporation
11.7.1 GeneScript Corporation Company Details
11.7.2 GeneScript Corporation Business Overview
11.7.3 GeneScript Corporation Expression Competent Cells Introduction
11.7.4 GeneScript Corporation Revenue in Expression Competent Cells Business (2018-2023)
11.7.5 GeneScript Corporation Recent Developments
11.8 Yeastern Biotech
11.8.1 Yeastern Biotech Company Details
11.8.2 Yeastern Biotech Business Overview
11.8.3 Yeastern Biotech Expression Competent Cells Introduction
11.8.4 Yeastern Biotech Revenue in Expression Competent Cells Business (2018-2023)
11.8.5 Yeastern Biotech Recent Developments
11.9 New England Biolabs
11.9.1 New England Biolabs Company Details
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs Expression Competent Cells Introduction
11.9.4 New England Biolabs Revenue in Expression Competent Cells Business (2018-2023)
11.9.5 New England Biolabs Recent Developments
11.10 QIAGEN N.V.
11.10.1 QIAGEN N.V. Company Details
11.10.2 QIAGEN N.V. Business Overview
11.10.3 QIAGEN N.V. Expression Competent Cells Introduction
11.10.4 QIAGEN N.V. Revenue in Expression Competent Cells Business (2018-2023)
11.10.5 QIAGEN N.V. Recent Developments
11.11 OriGene Technologies
11.11.1 OriGene Technologies Company Details
11.11.2 OriGene Technologies Business Overview
11.11.3 OriGene Technologies Expression Competent Cells Introduction
11.11.4 OriGene Technologies Revenue in Expression Competent Cells Business (2018-2023)
11.11.5 OriGene Technologies Recent Developments
11.12 Lucigen
11.12.1 Lucigen Company Details
11.12.2 Lucigen Business Overview
11.12.3 Lucigen Expression Competent Cells Introduction
11.12.4 Lucigen Revenue in Expression Competent Cells Business (2018-2023)
11.12.5 Lucigen Recent Developments
11.13 Zymo Research
11.13.1 Zymo Research Company Details
11.13.2 Zymo Research Business Overview
11.13.3 Zymo Research Expression Competent Cells Introduction
11.13.4 Zymo Research Revenue in Expression Competent Cells Business (2018-2023)
11.13.5 Zymo Research Recent Developments
11.14 Bio-Rad Laboratories
11.14.1 Bio-Rad Laboratories Company Details
11.14.2 Bio-Rad Laboratories Business Overview
11.14.3 Bio-Rad Laboratories Expression Competent Cells Introduction
11.14.4 Bio-Rad Laboratories Revenue in Expression Competent Cells Business (2018-2023)
11.14.5 Bio-Rad Laboratories Recent Developments
11.15 Bioline
11.15.1 Bioline Company Details
11.15.2 Bioline Business Overview
11.15.3 Bioline Expression Competent Cells Introduction
11.15.4 Bioline Revenue in Expression Competent Cells Business (2018-2023)
11.15.5 Bioline Recent Developments
11.16 Delphi Genetics
11.16.1 Delphi Genetics Company Details
11.16.2 Delphi Genetics Business Overview
11.16.3 Delphi Genetics Expression Competent Cells Introduction
11.16.4 Delphi Genetics Revenue in Expression Competent Cells Business (2018-2023)
11.16.5 Delphi Genetics Recent Developments
11.17 IBA GmBH
11.17.1 IBA GmBH Company Details
11.17.2 IBA GmBH Business Overview
11.17.3 IBA GmBH Expression Competent Cells Introduction
11.17.4 IBA GmBH Revenue in Expression Competent Cells Business (2018-2023)
11.17.5 IBA GmBH Recent Developments
11.18 Cell Applications
11.18.1 Cell Applications Company Details
11.18.2 Cell Applications Business Overview
11.18.3 Cell Applications Expression Competent Cells Introduction
11.18.4 Cell Applications Revenue in Expression Competent Cells Business (2018-2023)
11.18.5 Cell Applications Recent Developments
11.19 BioDynamics Laboratory
11.19.1 BioDynamics Laboratory Company Details
11.19.2 BioDynamics Laboratory Business Overview
11.19.3 BioDynamics Laboratory Expression Competent Cells Introduction
11.19.4 BioDynamics Laboratory Revenue in Expression Competent Cells Business (2018-2023)
11.19.5 BioDynamics Laboratory Recent Developments
11.20 Scarab Genomics
11.20.1 Scarab Genomics Company Details
11.20.2 Scarab Genomics Business Overview
11.20.3 Scarab Genomics Expression Competent Cells Introduction
11.20.4 Scarab Genomics Revenue in Expression Competent Cells Business (2018-2023)
11.20.5 Scarab Genomics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Expression Competent Cells Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Chemically Competent Cells
Table 3. Key Players of Electrocompetent Cells
Table 4. Global Expression Competent Cells Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Expression Competent Cells Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Expression Competent Cells Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Expression Competent Cells Market Share by Region (2018-2023)
Table 8. Global Expression Competent Cells Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Expression Competent Cells Market Share by Region (2024-2033)
Table 10. Expression Competent Cells Market Trends
Table 11. Expression Competent Cells Market Drivers
Table 12. Expression Competent Cells Market Challenges
Table 13. Expression Competent Cells Market Restraints
Table 14. Global Expression Competent Cells Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Expression Competent Cells Revenue Share by Players (2018-2023)
Table 16. Global Top Expression Competent Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Expression Competent Cells as of 2022)
Table 17. Global Expression Competent Cells Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Expression Competent Cells Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Expression Competent Cells, Headquarters and Area Served
Table 20. Global Key Players of Expression Competent Cells, Product and Application
Table 21. Global Key Players of Expression Competent Cells, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Expression Competent Cells Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Expression Competent Cells Revenue Market Share by Type (2018-2023)
Table 25. Global Expression Competent Cells Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Expression Competent Cells Revenue Market Share by Type (2024-2033)
Table 27. Global Expression Competent Cells Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Expression Competent Cells Revenue Share by Application (2018-2023)
Table 29. Global Expression Competent Cells Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Expression Competent Cells Revenue Share by Application (2024-2033)
Table 31. North America Expression Competent Cells Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Expression Competent Cells Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Expression Competent Cells Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Expression Competent Cells Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Expression Competent Cells Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Expression Competent Cells Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Expression Competent Cells Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Expression Competent Cells Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Expression Competent Cells Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Expression Competent Cells Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Expression Competent Cells Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Expression Competent Cells Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Expression Competent Cells Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Expression Competent Cells Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Expression Competent Cells Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Expression Competent Cells Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Expression Competent Cells Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Expression Competent Cells Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Expression Competent Cells Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Expression Competent Cells Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Expression Competent Cells Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Expression Competent Cells Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Expression Competent Cells Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Expression Competent Cells Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Expression Competent Cells Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Expression Competent Cells Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Expression Competent Cells Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Expression Competent Cells Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Expression Competent Cells Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Expression Competent Cells Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Expression Competent Cells Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Expression Competent Cells Market Size by Country (2024-2033) & (US$ Million)
Table 63. Merck KGaA Company Details
Table 64. Merck KGaA Business Overview
Table 65. Merck KGaA Expression Competent Cells Product
Table 66. Merck KGaA Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 67. Merck KGaA Recent Developments
Table 68. Thermo Fisher Scientific Company Details
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific Expression Competent Cells Product
Table 71. Thermo Fisher Scientific Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 72. Thermo Fisher Scientific Recent Developments
Table 73. Agilent Technologies Company Details
Table 74. Agilent Technologies Business Overview
Table 75. Agilent Technologies Expression Competent Cells Product
Table 76. Agilent Technologies Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 77. Agilent Technologies Recent Developments
Table 78. Takara Bio Company Details
Table 79. Takara Bio Business Overview
Table 80. Takara Bio Expression Competent Cells Product
Table 81. Takara Bio Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 82. Takara Bio Recent Developments
Table 83. Promega Corporation Company Details
Table 84. Promega Corporation Business Overview
Table 85. Promega Corporation Expression Competent Cells Product
Table 86. Promega Corporation Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 87. Promega Corporation Recent Developments
Table 88. Beijing TransGen Biotech Company Details
Table 89. Beijing TransGen Biotech Business Overview
Table 90. Beijing TransGen Biotech Expression Competent Cells Product
Table 91. Beijing TransGen Biotech Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 92. Beijing TransGen Biotech Recent Developments
Table 93. GeneScript Corporation Company Details
Table 94. GeneScript Corporation Business Overview
Table 95. GeneScript Corporation Expression Competent Cells Product
Table 96. GeneScript Corporation Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 97. GeneScript Corporation Recent Developments
Table 98. Yeastern Biotech Company Details
Table 99. Yeastern Biotech Business Overview
Table 100. Yeastern Biotech Expression Competent Cells Product
Table 101. Yeastern Biotech Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 102. Yeastern Biotech Recent Developments
Table 103. New England Biolabs Company Details
Table 104. New England Biolabs Business Overview
Table 105. New England Biolabs Expression Competent Cells Product
Table 106. New England Biolabs Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 107. New England Biolabs Recent Developments
Table 108. QIAGEN N.V. Company Details
Table 109. QIAGEN N.V. Business Overview
Table 110. QIAGEN N.V. Expression Competent Cells Product
Table 111. QIAGEN N.V. Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 112. QIAGEN N.V. Recent Developments
Table 113. OriGene Technologies Company Details
Table 114. OriGene Technologies Business Overview
Table 115. OriGene Technologies Expression Competent Cells Product
Table 116. OriGene Technologies Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 117. OriGene Technologies Recent Developments
Table 118. Lucigen Company Details
Table 119. Lucigen Business Overview
Table 120. Lucigen Expression Competent Cells Product
Table 121. Lucigen Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 122. Lucigen Recent Developments
Table 123. Zymo Research Company Details
Table 124. Zymo Research Business Overview
Table 125. Zymo Research Expression Competent Cells Product
Table 126. Zymo Research Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 127. Zymo Research Recent Developments
Table 128. Bio-Rad Laboratories Company Details
Table 129. Bio-Rad Laboratories Business Overview
Table 130. Bio-Rad Laboratories Expression Competent Cells Product
Table 131. Bio-Rad Laboratories Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 132. Bio-Rad Laboratories Recent Developments
Table 133. Bioline Company Details
Table 134. Bioline Business Overview
Table 135. Bioline Expression Competent Cells Product
Table 136. Bioline Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 137. Bioline Recent Developments
Table 138. Delphi Genetics Company Details
Table 139. Delphi Genetics Business Overview
Table 140. Delphi Genetics Expression Competent Cells Product
Table 141. Delphi Genetics Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 142. Delphi Genetics Recent Developments
Table 143. IBA GmBH Company Details
Table 144. IBA GmBH Business Overview
Table 145. IBA GmBH Expression Competent Cells Product
Table 146. IBA GmBH Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 147. IBA GmBH Recent Developments
Table 148. Cell Applications Company Details
Table 149. Cell Applications Business Overview
Table 150. Cell Applications Expression Competent Cells Product
Table 151. Cell Applications Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 152. Cell Applications Recent Developments
Table 153. BioDynamics Laboratory Company Details
Table 154. BioDynamics Laboratory Business Overview
Table 155. BioDynamics Laboratory Expression Competent Cells Product
Table 156. BioDynamics Laboratory Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 157. BioDynamics Laboratory Recent Developments
Table 158. Scarab Genomics Company Details
Table 159. Scarab Genomics Business Overview
Table 160. Scarab Genomics Expression Competent Cells Product
Table 161. Scarab Genomics Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 162. Scarab Genomics Recent Developments
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Expression Competent Cells Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Expression Competent Cells Market Share by Type: 2022 VS 2033
Figure 3. Chemically Competent Cells Features
Figure 4. Electrocompetent Cells Features
Figure 5. Global Expression Competent Cells Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Expression Competent Cells Market Share by Application: 2022 VS 2033
Figure 7. Protein Expression Case Studies
Figure 8. Other Case Studies
Figure 9. Expression Competent Cells Report Years Considered
Figure 10. Global Expression Competent Cells Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global Expression Competent Cells Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Expression Competent Cells Market Share by Region: 2022 VS 2033
Figure 13. Global Expression Competent Cells Market Share by Players in 2022
Figure 14. Global Top Expression Competent Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Expression Competent Cells as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Expression Competent Cells Revenue in 2022
Figure 16. North America Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America Expression Competent Cells Market Share by Type (2018-2033)
Figure 18. North America Expression Competent Cells Market Share by Application (2018-2033)
Figure 19. North America Expression Competent Cells Market Share by Country (2018-2033)
Figure 20. United States Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Expression Competent Cells Market Size YoY (2018-2033) & (US$ Million)
Figure 23. Europe Expression Competent Cells Market Share by Type (2018-2033)
Figure 24. Europe Expression Competent Cells Market Share by Application (2018-2033)
Figure 25. Europe Expression Competent Cells Market Share by Country (2018-2033)
Figure 26. Germany Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. China Expression Competent Cells Market Size YoY (2018-2033) & (US$ Million)
Figure 33. China Expression Competent Cells Market Share by Type (2018-2033)
Figure 34. China Expression Competent Cells Market Share by Application (2018-2033)
Figure 35. Asia Expression Competent Cells Market Size YoY (2018-2033) & (US$ Million)
Figure 36. Asia Expression Competent Cells Market Share by Type (2018-2033)
Figure 37. Asia Expression Competent Cells Market Share by Application (2018-2033)
Figure 38. Asia Expression Competent Cells Market Share by Region (2018-2033)
Figure 39. Japan Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. South Korea Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. China Taiwan Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Southeast Asia Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. India Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Australia Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America Expression Competent Cells Market Size YoY (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Expression Competent Cells Market Share by Type (2018-2033)
Figure 47. Middle East, Africa, and Latin America Expression Competent Cells Market Share by Application (2018-2033)
Figure 48. Middle East, Africa, and Latin America Expression Competent Cells Market Share by Country (2018-2033)
Figure 49. Brazil Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Mexico Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Turkey Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Saudi Arabia Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Israel Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. GCC Countries Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Merck KGaA Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 57. Agilent Technologies Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 58. Takara Bio Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 59. Promega Corporation Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 60. Beijing TransGen Biotech Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 61. GeneScript Corporation Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 62. Yeastern Biotech Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 63. New England Biolabs Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 64. QIAGEN N.V. Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 65. OriGene Technologies Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 66. Lucigen Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 67. Zymo Research Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 68. Bio-Rad Laboratories Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 69. Bioline Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 70. Delphi Genetics Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 71. IBA GmBH Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 72. Cell Applications Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 73. BioDynamics Laboratory Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 74. Scarab Genomics Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed